Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
In relation to Commission Implementing Regulation (EU) 2024/2174 of 2 September 2024 laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council […]
We are pleased to announce the launch of a new version of the Clinical Trials Information System (CTIS) public portal, which will allow earlier and more efficient access to clinical
New version of the Clinical Trials Information System (CTIS) public portal Read More »
JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of
JAZMP AVAILABLE TO ACT AS REFERENCE MEMBER STATE (RMS) IN MRP AND DCP PROCEDURES Read More »
JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of
JAZMP AVAILABLE TO ACT AS REFERENCE MEMBER STATE (RMS) IN MRP AND DCP PROCEDURES Read More »
The stabilisation period in Slovenia, introduced after the implementation of Commission Delegated Regulation 2016/161, ended on 1st of December 2019. Therefore the Agency for Medicinal Products and Medical Devices of
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
With this announcement we would like to inform all Applicants that the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia still has capacities to act as
Agency for Medicinal Products and Medical devices of the Republic of Slovenia (JAZMP) participates in the decentralised procedure as a RMS. JAZMP will accept to act as RMS for as
Request for time slot for applications via DCP with Slovenia as RMS Read More »
